Cardio Diagnostics Holdings Inc
NASDAQ:CDIO

Watchlist Manager
Cardio Diagnostics Holdings Inc Logo
Cardio Diagnostics Holdings Inc
NASDAQ:CDIO
Watchlist
Price: 1.81 USD
Market Cap: 3.3m USD

Net Margin

-41 455.7%
Current
Declining
by 2 347.9%
vs 3-y average of -39 107.8%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-41 455.7%
=
Net Income
$-6.6m
/
Revenue
$15.8k

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-41 455.7%
=
Net Income
$-6.6m
/
Revenue
$15.8k

Peer Comparison

Country Company Market Cap Net
Margin
US
Cardio Diagnostics Holdings Inc
NASDAQ:CDIO
3.2m USD
Loading...
IN
Aaswa Trading and Exports Ltd
BSE:512038
25.7T INR
Loading...
US
GE Vernova LLC
NYSE:GEV
185.8B USD
Loading...
UK
Eight Capital Partners PLC
F:ECS
158.4B EUR
Loading...
US
China Industrial Group Inc
OTC:CIND
121B USD
Loading...
NL
Nepi Rockcastle NV
JSE:NRP
88.9B Zac
Loading...
US
Schlumberger NV
NYSE:SLB
69.8B USD
Loading...
IN
GTV Engineering Ltd
BSE:539479
4.7T INR
Loading...
US
Baker Hughes Co
NASDAQ:BKR
51B USD
Loading...
US
CoreWeave Inc
NASDAQ:CRWV
46.5B USD
Loading...
CH
Galderma Group AG
SIX:GALD
36.4B CHF
Loading...
No Stocks Found

Market Distribution

Lower than 99% of companies in the United States of America
Percentile
1st
Based on 15 072 companies
1st percentile
-41 455.7%
Low
-4 418 600% — -9.6%
Typical Range
-9.6% — 11.3%
High
11.3% — 1 135 400%
Distribution Statistics
the United States of America
Min -4 418 600%
30th Percentile -9.6%
Median 3.1%
70th Percentile 11.3%
Max 1 135 400%

Cardio Diagnostics Holdings Inc
Glance View

Market Cap
3.3m USD
Industry
N/A

Cardio Diagnostics Holdings Inc is a US-based company operating in industry. The company is headquartered in Dover, Delaware. The company went IPO on 2021-11-23. Cardio Diagnostics Holdings, Inc., formerly Mana Capital Acquisition Corp., is a biotechnology company that helps in cardiovascular disease prevention and early detection accessible. The firm is engaged in the development and commercialization of artificial intelligence (AI)-driven Integrated Genetic-Epigenetic Engine for cardiovascular disease. The company enables prevention, early detection, and assists in the treatment of cardiovascular disease. The firm's Epi+Gen CHD is a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks. Its Epi+Gen CHD test is categorized as a laboratory-developed test (LDT), which does not require premarket authorization or other Food and Drug Administration (FDA) clearance or approval. The company serves a range of patients, clinicians, hospitals/health systems, employers, and payors.

CDIO Intrinsic Value
HIDDEN
Show
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-41 455.7%
=
Net Income
$-6.6m
/
Revenue
$15.8k
What is Cardio Diagnostics Holdings Inc's current Net Margin?

The current Net Margin for Cardio Diagnostics Holdings Inc is -41 455.7%, which is below its 3-year median of -39 107.8%.

How has Net Margin changed over time?

Over the last 2 years, Cardio Diagnostics Holdings Inc’s Net Margin has increased from -93 600% to -41 455.7%. During this period, it reached a low of -93 600% on Sep 30, 2023 and a high of -22 430.9% on Jun 30, 2024.

Back to Top